These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8257833)

  • 1. [Chinese material medica combined with cisplatin and lipiodol through transcatheter arterial embolization in the treatment of primary hepatoma].
    Yu ZJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jun; 13(6):327-9, 323. PubMed ID: 8257833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
    Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
    Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinoma.
    Yu ZJ; Yu JW; Cai W; Yuan HX; Li XY; Yuan Y; Chen JP; Wu XY; Yao DF
    World J Gastroenterol; 2005 Sep; 11(33):5221-5. PubMed ID: 16127757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
    Wang Y; Zheng C; Liang B; Zhao H; Qian J; Liang H; Feng G
    J Vasc Interv Radiol; 2011 Nov; 22(11):1606-12. PubMed ID: 21959058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
    Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
    Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Large amount of intra-arterial injection of iodized oil (Lipiodol) in the treatment of unresectable hepatoma].
    Onodera H; Oikawa M; Abe M; Chida N; Kimura S; Goto Y
    Rinsho Hoshasen; 1986 Feb; 31(2):269-73. PubMed ID: 3012157
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-hepatic artery infusional chemotherapy with cisplatin suspension in lipiodol (LPS) of hepatocellular carcinoma (II)--A clinical study].
    Shibata J; Kimura S; Chikazawa H; Miyase S; Sakai M; Morishita T; Fujiyama S; Sato T; Fukushima S; Kishimoto S
    Nihon Gan Chiryo Gakkai Shi; 1988 Dec; 23(11):2750-9. PubMed ID: 2854838
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma.
    Ono Y; Yoshimasu T; Ashikaga R; Inoue M; Shindou H; Fuji K; Araki Y; Nishimura Y
    Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoembolization therapy with lipiodol, cisplatin and etoposide for hepatocellular carcinoma].
    Inoue A; Kojima J; Kasugai H; Okuda S; Fujita M; Shibata K; Sasaki Y; Imaoka S; Ishiguro S
    Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2788-93. PubMed ID: 1963631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma].
    Yodono H; Tarusawa K; Kanehira J; Fukuda E; Ikami I; Sakaki T; Kamata K; Sasaki D; Sasaki M
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3476-82. PubMed ID: 3024580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter).
    Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S
    Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity reactions to transcatheter chemoembolization with cisplatin and Lipiodol suspension for unresectable hepatocellular carcinoma.
    Kawaoka T; Aikata H; Katamura Y; Takaki S; Waki K; Hiramatsu A; Takahashi S; Hieda M; Kakizawa H; Chayama K
    J Vasc Interv Radiol; 2010 Aug; 21(8):1219-25. PubMed ID: 20619676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
    Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation.
    Yamashita Y; Torashima M; Oguni T; Yamamoto A; Harada M; Miyazaki T; Takahashi M
    Abdom Imaging; 1993; 18(4):352-6. PubMed ID: 8220035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sequential hepatic artery and portal vein embolization using lipiodol-adriamycin for primary liver cancer].
    Pan CE
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):372-4. PubMed ID: 1664318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.